AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3862020 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti‐inflammatory agents
Number of subjects: 0
Study 3862020 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of corticosteroids and nonsteroidal anti‐inflammatory agents
Number of subjects: 0
Study 3862020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28651477 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal Management Training (GMT)
Number of subjects: 70
Study 28651477 — intervention group
Group type: COMPARATOR
Intervention: Active psycho-educative control intervention
Number of subjects: 70
Study 28366780 — intervention group
Group type: EXPERIMENTAL
Intervention: ED‐focused intervention to improve the quality of care on discharge to home
Number of subjects: 0
Study 28366780 — intervention group
Group type: EXPERIMENTAL
Intervention: ED‐focused intervention together with a home‐based community health worker (CHW)‐led intervention
Number of subjects: 0
Study 28366780 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 0
Study 26571831 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 347
Study 26571831 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 347
Study 23508601 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (point-of-care education, coaching, medication intensification)
Number of subjects: 727
Study 23508601 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 727
Study 21969080 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 25
Study 21969080 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 25
Study 21969080 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 25
Study 18850104 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisturizer 1
Number of subjects: 20
Study 18850104 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisturizer 2
Number of subjects: 20
Study 16736000 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (1.2 mg day(‐1) for 12 weeks)
Number of subjects: 61
Study 15196414 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted sigmoid colpopoiesis
Number of subjects: 9
Study 15196414 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sigmoid colon colpopoiesis
Number of subjects: 9
Study 11577960 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration (GTR) using a bioabsorbable bilayer collagen membrane
Number of subjects: 20
Study 11577960 — intervention group
Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft (CTG)
Number of subjects: 20
Study 10079865 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiramycin
Number of subjects: 65
Study 10079865 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 65
Study 8273956 — intervention group
Group type: EXPERIMENTAL
Intervention: NMB-assisted oral intubation (succinylcholine 1.5 mg/kg IV)
Number of subjects: 77
Study 8273956 — intervention group
Group type: COMPARATOR
Intervention: Nasotracheal intubation (NTI)
Number of subjects: 77
Study 8273956 — intervention group
Group type: EXPERIMENTAL
Intervention: NMB-assisted oral intubation
Number of subjects: 77
Study 3341821 — intervention group
Group type: EXPERIMENTAL
Intervention: Nissen operation
Number of subjects: 50
Study 3341821 — intervention group
Group type: COMPARATOR
Intervention: Belsey operation
Number of subjects: 50
Study 3341821 — intervention group
Group type: EXPERIMENTAL
Intervention: Resection plus colon interposition
Number of subjects: 50
Study 3341821 — intervention group
Group type: EXPERIMENTAL
Intervention: Resection plus gastric interposition
Number of subjects: 50
Study 30843497 — intervention group
Group type: EXPERIMENTAL
Intervention: Ma‐al‐Shaeer (MS) 15 g of dried MS powder twice daily for 14 days
Number of subjects: 77
Study 30843497 — intervention group
Group type: COMPARATOR
Intervention: Fexofenadine (FX) 60 mg twice daily for 14 days
Number of subjects: 77
Study 28720336 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate/formoterol fumarate (GFF) metered dose inhaler (MDI) 18/9.6 μg
Number of subjects: 3699
Study 28720336 — intervention group
Group type: COMPARATOR
Intervention: Monocomponent MDIs and placebo MDI
Number of subjects: 3699
Study 25495272 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential therapy (5-day dual therapy with pantoprazole plus amoxicillin, followed by 5-day triple therapy with pantoprazole plus clarithromycin and metronidazole)
Number of subjects: 122
Study 25495272 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse sequential therapy (5-day triple therapy with pantoprazole plus clarithromycin and metronidazole, followed by 5-day dual therapy with pantoprazole plus amoxicillin)
Number of subjects: 122
Study 25495272 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential therapy
Number of subjects: 122
Study 25495272 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse sequential therapy
Number of subjects: 122
Study 25495272 — intervention group
Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 122
Study 23841268 — intervention group
Group type: EXPERIMENTAL
Intervention: CMHSTBNA (Chinese medical herbs for Shen tonifying, blood nourishing and activating)
Number of subjects: 368
Study 21740077 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose pantoprazole (0.6 mg/kg equivalent)
Number of subjects: 60
Study 21740077 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose pantoprazole (1.2 mg/kg equivalent)
Number of subjects: 60
Study 21740077 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole (both doses)
Number of subjects: 60
Study 20144434 — intervention group
Group type: EXPERIMENTAL
Intervention: MedTone inhaler with TI powder
Number of subjects: 56
Study 16706571 — intervention group
Group type: EXPERIMENTAL
Intervention: Reimbursement for smoking cessation treatment (SCT) for 6 months
Number of subjects: 1266
Study 16706571 — intervention group
Group type: COMPARATOR
Intervention: No reimbursement (control group)
Number of subjects: 1266
Study 16706571 — intervention group
Group type: EXPERIMENTAL
Intervention: Reimbursement for SCT
Number of subjects: 1266
Study 15321933 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil target concentration of 5 ng ml(‐1)
Number of subjects: 81
Study 15321933 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil target concentration of 10 ng ml(‐1)
Number of subjects: 81
Study 15321933 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil target concentration of 15 ng ml(‐1)
Number of subjects: 81
Study 15321933 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuff inflation with remifentanil
Number of subjects: 81
Study 15321933 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheal suctioning with remifentanil
Number of subjects: 81
Study 15321933 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheal suctioning
Number of subjects: 81
Study 11763924 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiBond (dual-cure glass filled adhesive) applied to 85 teeth
Number of subjects: 38
Study 11763924 — intervention group
Group type: COMPARATOR
Intervention: Delton (self-cured sealant) applied to 86 teeth
Number of subjects: 38
Study 9494176 — intervention group
Group type: EXPERIMENTAL
Intervention: Patch angioplasty
Number of subjects: 758
Study 8336169 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP)
Number of subjects: 70
Study 8336169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 3109574 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous calcium heparin
Number of subjects: 100
Study 3109574 — intervention group
Group type: COMPARATOR
Intervention: Intravenous sodium heparin
Number of subjects: 100
Study 29362250 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based sustainability programme
Number of subjects: 0
Study 29362250 — intervention group
Group type: COMPARATOR
Intervention: Minimal contact programme
Number of subjects: 0
Study 27087212 — intervention group
Group type: EXPERIMENTAL
Intervention: Health management group
Number of subjects: 618
Study 27087212 — intervention group
Group type: COMPARATOR
Intervention: General management group
Number of subjects: 618
Study 23899896 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 3899
Study 22987210 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-minute motivational/skills-building counseling session
Number of subjects: 307
Study 22987210 — intervention group
Group type: COMPARATOR
Intervention: Written HIV prevention information material
Number of subjects: 307
Study 19968833 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine 2.5 mg/day
Number of subjects: 60
Study 19968833 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine 5 mg/day
Number of subjects: 60
Study 19968833 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine 10 mg/day
Number of subjects: 60
Study 19968833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 19968833 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (all doses)
Number of subjects: 60
Study 18441691 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment adherence
Number of subjects: 1298
Study 18441691 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasons for missed drug intake
Number of subjects: 1298
Study 18441691 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient vs Physician interpretation of hypertension problems
Number of subjects: 1298
Study 18441691 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to regular drug intake
Number of subjects: 1298
Study 18441691 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement strategies for compliance
Number of subjects: 1298
Study 16784343 — intervention group
Group type: EXPERIMENTAL
Intervention: High epistemic motivation (EM) with cooperative tactics
Number of subjects: 0
Study 16784343 — intervention group
Group type: EXPERIMENTAL
Intervention: High epistemic motivation (EM) with competitive tactics
Number of subjects: 0
Study 16784343 — intervention group
Group type: EXPERIMENTAL
Intervention: Low epistemic motivation (EM)
Number of subjects: 0
Study 15213617 — intervention group
Group type: EXPERIMENTAL
Intervention: S
Number of subjects: 589
Study 15213617 — intervention group
Group type: EXPERIMENTAL
Intervention: SRT
Number of subjects: 589
Study 15213617 — intervention group
Group type: EXPERIMENTAL
Intervention: SCT
Number of subjects: 589
Study 15213617 — intervention group
Group type: EXPERIMENTAL
Intervention: CT
Number of subjects: 589
Study 12184354 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 0
Study 12184354 — intervention group
Group type: COMPARATOR
Intervention: Control group interventions
Number of subjects: 0
Study 9546995 — intervention group
Group type: EXPERIMENTAL
Intervention: Device therapy in a blinded manner
Number of subjects: 0
Study 9546995 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical outcomes
Number of subjects: 0
Study 8391856 — intervention group
Group type: EXPERIMENTAL
Intervention: N-9 once every other day
Number of subjects: 35
Study 8391856 — intervention group
Group type: EXPERIMENTAL
Intervention: N-9 once a day
Number of subjects: 35
Study 8391856 — intervention group
Group type: EXPERIMENTAL
Intervention: N-9 twice a day
Number of subjects: 35
Study 8391856 — intervention group
Group type: EXPERIMENTAL
Intervention: N-9 4 times a day
Number of subjects: 35
Study 8391856 — intervention group
Group type: COMPARATOR
Intervention: Placebo 4 times a day
Number of subjects: 35
Study 3085914 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA-enriched TPN
Number of subjects: 10
Study 3085914 — intervention group
Group type: COMPARATOR
Intervention: Conventional TPN
Number of subjects: 10
Study 30615139 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer modeling risky behaviors
Number of subjects: 137
Study 30615139 — intervention group
Group type: COMPARATOR
Intervention: Peer observation
Number of subjects: 137
Study 30615139 — intervention group
Group type: COMPARATOR
Intervention: Safe modeling
Number of subjects: 137
Study 28259499 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5‐10mg) for 8 weeks
Number of subjects: 88
Study 28259499 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone (12.5‐25mg) for 8 weeks
Number of subjects: 88
Study 25702618 — intervention group
Group type: EXPERIMENTAL
Intervention: 5mg/day rosuvastatin for 6 months
Number of subjects: 24
Study 25702618 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 24080019 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecstasy polydrug users
Number of subjects: 60
Study 24080019 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonecstasy polydrug users
Number of subjects: 60
Study 24080019 — intervention group
Group type: COMPARATOR
Intervention: Drug naive controls
Number of subjects: 60
Study 21048776 — intervention group
Group type: EXPERIMENTAL
Intervention: Single width blood pressure cuff (12 cm)
Number of subjects: 101
Study 21048776 — intervention group
Group type: COMPARATOR
Intervention: Proportional width blood pressure cuff
Number of subjects: 101
Study 19264929 — intervention group
Group type: EXPERIMENTAL
Intervention: Concept-Oriented Reading Instruction (CORI)
Number of subjects: 0
Study 19264929 — intervention group
Group type: COMPARATOR
Intervention: Traditional Instruction (TI)
Number of subjects: 0
Study 17685781 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching primer (SEP) application for 3 to 5 seconds
Number of subjects: 40
Study 17685781 — intervention group
Group type: COMPARATOR
Intervention: Self-etching primer (SEP) application for 15 seconds
Number of subjects: 40
Study 17685781 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of ARI scores between both groups
Number of subjects: 40
Study 15339055 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin/gemcitabine combination
Number of subjects: 0
Study 15339055 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin/gemcitabine combination (3-week schedule)
Number of subjects: 0
Study 11334591 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDLINE articles
Number of subjects: 6766
Study 11334591 — intervention group
Group type: EXPERIMENTAL
Intervention: IME articles
Number of subjects: 6766
Study 11334591 — intervention group
Group type: EXPERIMENTAL
Intervention: semFYC congress summaries
Number of subjects: 6766
Study 11334591 — intervention group
Group type: COMPARATOR
Intervention: Review articles
Number of subjects: 6766
Study 9215837 — intervention group
Group type: EXPERIMENTAL
Intervention: CVPP (3 cycles)
Number of subjects: 256
Study 9215837 — intervention group
Group type: EXPERIMENTAL
Intervention: CVPP (6 cycles)
Number of subjects: 256
Study 9215837 — intervention group
Group type: EXPERIMENTAL
Intervention: CVPP plus RT
Number of subjects: 256
Study 9215837 — intervention group
Group type: COMPARATOR
Intervention: AOPE plus RT
Number of subjects: 256
Study 8432481 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose cyclosporin (4.1 mg/kg/day)
Number of subjects: 35
Study 8432481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 2835836 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical antibiotic preparation (neomycin, bacitracin, and polymyxin B)
Number of subjects: 30
Study 2835836 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 31251352 — intervention group
Group type: EXPERIMENTAL
Intervention: S. haematobium with hybrid ancestry from S. bovis
Number of subjects: 96
Study 31251352 — intervention group
Group type: EXPERIMENTAL
Intervention: S. bovis-derived alleles
Number of subjects: 96
Study 31251352 — intervention group
Group type: EXPERIMENTAL
Intervention: Invadolysin gene family
Number of subjects: 96
Study 28008749 — intervention group
Group type: EXPERIMENTAL
Intervention: INSIGHT responsive parenting intervention
Number of subjects: 291
Study 28008749 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 291
Study 25579833 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth Aware of Mental Health Programme (YAM)
Number of subjects: 11110
Study 25579833 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 11110
Study 24201233 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) up to 2 g/d
Number of subjects: 42
Study 24201233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 21632725 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-to-Family Education Program (FTF)
Number of subjects: 318
Study 21632725 — intervention group
Group type: COMPARATOR
Intervention: Control group (waitlisted participants)
Number of subjects: 318
Study 19370425 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton-beam therapy (PBT)
Number of subjects: 24
Study 19370425 — intervention group
Group type: COMPARATOR
Intervention: 3D conformal X-ray therapy (3D-CRT)
Number of subjects: 24
Study 16674614 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasopharyngeal oxygen insufflation at a flow of 5 l.min(‐1)
Number of subjects: 30
Study 16674614 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nasopharyngeal oxygen insufflation)
Number of subjects: 30
Study 14571613 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangxin capsule (KXC)
Number of subjects: 63
Study 14571613 — intervention group
Group type: COMPARATOR
Intervention: Hydergine
Number of subjects: 63
Study 11089449 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (40 mg, p.o.)
Number of subjects: 4
Study 11089449 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 4
Study 8986480 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratracheal oxygen insufflation (ITO2) via minitracheotomy (MT)
Number of subjects: 20
Study 1456568 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional therapy (controlled nutritional support)
Number of subjects: 0
Study 3842839 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous stimulation at 60 db SPL for 7 min in the R ear during Phase II
Number of subjects: 15
Study 3842839 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent stimulation in the contralateral ear during Phase III
Number of subjects: 15
Study 3842839 — intervention group
Group type: COMPARATOR
Intervention: Simultaneous, intermittent stimulation in both ears during Phase I
Number of subjects: 15
Study 31337298 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment with successful reperfusion
Number of subjects: 2794
Study 31337298 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alteplase before endovascular treatment
Number of subjects: 2794
Study 31337298 — intervention group
Group type: EXPERIMENTAL
Intervention: No interhospital transfer
Number of subjects: 2794
Study 31337298 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower stroke severity
Number of subjects: 2794
Study 31337298 — intervention group
Group type: EXPERIMENTAL
Intervention: Smaller infarct size
Number of subjects: 2794
Study 31337298 — intervention group
Group type: EXPERIMENTAL
Intervention: Reperfusion success
Number of subjects: 2794
Study 30045101 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lateral approach for proximal sciatic nerve block
Number of subjects: 40
Study 30045101 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided anterior approach for proximal sciatic nerve block
Number of subjects: 40
Study 30045101 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadaveric evaluation of the lateral approach
Number of subjects: 40
Study 26603740 — intervention group
Group type: EXPERIMENTAL
Intervention: High volume aerobic exercise (300 minutes/week)
Number of subjects: 400
Study 26603740 — intervention group
Group type: COMPARATOR
Intervention: Moderate volume aerobic exercise (150 minutes/week)
Number of subjects: 400
Study 26603740 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected exercise level >246 minutes/week
Number of subjects: 400
Study 26603740 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected exercise level <110 minutes/week
Number of subjects: 400
Study 26603740 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise time in target heart rate zone
Number of subjects: 400
Study 24758079 — intervention group
Group type: EXPERIMENTAL
Intervention: Busheng Huoxue Capsule (BHC) plus caltrate-D (600 mg CaCO3)
Number of subjects: 200
Study 24758079 — intervention group
Group type: COMPARATOR
Intervention: Alendronate (70 mg per week) plus caltrate-D
Number of subjects: 200
Study 24758079 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (BHC and Alendronate)
Number of subjects: 200
Study 23106761 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Cognitive Processing Therapy (MCPT)
Number of subjects: 100
Study 23106761 — intervention group
Group type: COMPARATOR
Intervention: Stressor sessions
Number of subjects: 100
Study 20124230 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended therapy (Nicoderm CQ, 21 mg, for 24 weeks)
Number of subjects: 568
Study 18406951 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially restricted splint
Number of subjects: 42
Study 18406951 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly restricted splint
Number of subjects: 42
Study 18406951 — intervention group
Group type: COMPARATOR
Intervention: Baseline (no splint)
Number of subjects: 42
Study 15935090 — intervention group
Group type: EXPERIMENTAL
Intervention: Homozygotes for the minor alleles of STAT3 polymorphisms
Number of subjects: 1053
Study 15935090 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated measures of FEV1 over 8 weeks
Number of subjects: 1053
Study 15935090 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype analysis based on six polymorphisms
Number of subjects: 1053
Study 15935090 — intervention group
Group type: EXPERIMENTAL
Intervention: One polymorphism in childhood asthmatics
Number of subjects: 1053
Study 12542901 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of cefepime (4-g continuous infusion over 24 h for 48 h)
Number of subjects: 10
Study 12542901 — intervention group
Group type: COMPARATOR
Intervention: Intermittent injection of cefepime (2-g bolus every 12 h for 48 h)
Number of subjects: 10
Study 10776311 — intervention group
Group type: EXPERIMENTAL
Intervention: Almarys Optima
Number of subjects: 0
Study 10776311 — intervention group
Group type: EXPERIMENTAL
Intervention: Almaris Quiet
Number of subjects: 0